Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Blood. Found 4 abstracts

Jimbo M, Myers RE, Meyer B, Hyslop T, Cocroft J, Turner BJ, Weinberg DS. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Annals of Family Medicine. 2009 Jan;7(1):11-6.   PMCID: PMC2625842
Adams GP, Simmons HH, Yuan Q, Marasco W, Mehta S. Anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer. 2005 Jul 08;:80 pp.
He J, Smith ER, Xu XX. Disabled-2 exerts its tumor suppressor activity by uncoupling c-Fos expression and MAP kinase activation. The Journal of biological chemistry. 2001 Jul 20;276(29):26814-8.
Much JK, Cotteta TA. Stress of occupational exposure to blood or body fluids: managing the response. MEDSURG Nursing. 1993 Feb;2(1):49-56.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Blood

Blood Human antibody conjugated with Pseudomonas (exotoxin PRP (Properties) Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (single chain-Fv-anti-MISIIR aspirate Mammary gland (nipple Testis (treatment of Bacteriophage unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (RIP (ribosome-inactivating protein)-antibody conjugated with Intervention pf [Psychosocial Factors] Cultured Tumor Cells Imaging agents cDNA sequences (anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer) mullerian inhibiting substance receptor MISIIR immunoconjugate human cancer Prostate gland Blood plasma antagonists & inhibitors Proteins st [Standards] Peptide nucleic acids antibody conjugated with Drug delivery systems (prodrugs Antitumor agents Lung (toxicity Plasmid vectors unclassified) Antibodies and Immunoglobulins Role: BSU (Biological study-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (labeled Urine Chemotherapy (antibody conjugated with Tumor Suppressor Genes treatment of Carcinoma (cervix Mammary gland Diagnosis Proto-Oncogene Proteins Enzyme Inhibitors Transfection unclassified) Hormone receptors Role: BSU (Biological study-BIOL (Biological study) (Mullerian-inhibiting hormone-type II PRP (Properties) Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (anti-MISIIR unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (momordins-antibody conjugated with Abrins Flow Cytometry metabolism Cancer Screening Proto-Oncogene Proteins c-fos Testis Ovary Non-US Gov't Support Cosmids Occupational Exposure Gene therapy Enzyme Activation Physicians genetics physiology carcinoma Uterus (cervix-treatment of Radionuclides magnetic Spheres (beads-antibody conjugated with Mitogen-Activated Protein Kinases unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (PAP (pokeweed antiviral protein)-antibody conjugated with or (MISIIR) immunoconjugates to detect and treat cancer) unclassified) Toxins Role: BSU (Biological study-BIOL (Biological study) (antibody conjugated with Body Fluids anti-Mullerian inhibiting substance type II recep tm [Transmission] Mandatory Reporting Viral vectors pharmacology Phosphorylation Blood cell Uterus (cervix Neoplasms US Gov't Support-PHS Lung anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer) Diagnosis (cancer unclassified) Toxins Role: BSU (Biological study-BIOL (Biological study) (diphtheria-antibody conjugated with Ricins HIV Infections Drug delivery systems (immunoconjugates Fear
Last updated on Saturday, July 04, 2020